Perceptive Advisors has made global investments in public and private companies developing biotechnology products, drugs, medical devices and diagnostics for over 24 years. We invest throughout a company’s life cycle to help facilitate robust development programs: our capabilities include participating in early and late stage venture, crossover rounds, leading IPOs, and public follow on financings. The majority of our investments are in publicly-traded companies ranging from small to mid-capitalization. Our investment team uses a fundamental scientific approach to develop proprietary research, enabling us to make investments with conviction.
We invest in companies focused on the following areas of healthcare: